
Vice President, Corporate Securities and Transactions
Allogene Therapeutics340 000 $ – 380 000 $ / yil
GibridTo‘liq stavkaYetakchiTalab Qilinadigan Til: inglizchaVitse-prezidentLead SEC reporting, corporate governance, and strategic transaction matters for Allogene Therapeutics, a clinical-stage biotechnology company developing off-the-shelf CAR T therapies.
Ochish